- Nashville-based healthcare data analytics software provider Stratasan announced it raised $26 million
Stratasan — a Nashville-based healthcare data analytics software provider — announced it has raised $26 million in funding led by Fulcrum Equity Partners with participation from Frist Cressey Ventures, Blue Heron Capital, Bridge Bank, and company management. And Stratasan will be using the funding to further expand its product offerings as well as invest in its sales, marketing, and customer success teams.
What does Stratasan do? Stratasan is a leading provider of analytics software and services that provides market intelligence to hospitals and healthcare systems — which equips them to make better strategic growth decisions.
“We are profoundly grateful for the opportunity to partner with three operationally focused growth equity firms to begin the next chapter in our journey,” said Stratasan co-founder and CEO Jason Moore. “We’ve built a customer-first culture, and our entire team is looking forward to providing increased value to our current and future customers through this new investment. As we look to the future, I want to be sure to also thank our current investors and the TNInvestCo program, as they were pivotal in helping us get to where we are today.”
And by serving as a hub for business development intelligence, Stratasan provides a foundation for growth in the areas of strategic planning, marketing, physician relations, and expansion. And Stratasan offers access to all-payer claims data (APCD) and curates, aggregates, and supports the use of state, EMR, and Medicare data within their software platform.
“The business of operating and growing a healthcare organization can be difficult and complex,” added Fulcrum Principal Philip Lewis. “However, with Stratasan’s powerful analytics software tools, administrators and operators are able to make data-driven, fact-based decisions around how to grow their organizations and thrive in a competitive market.”
Along with the investor group, seasoned operators Ken Walters (former President of Infor) and Jim Riley (former CEO of Capario) is joining the Stratasan board of directors while Jim Phillips and Steve Geringer of XMi High Growth Development Fund and Nancy Allen of Rolling Hills Capital will be exiting.
“Stratasan’s market-leading solutions equip leading healthcare organizations with the intelligence they need to make informed strategic decisions and appropriately deploy resources. As a result, Stratasan enables these organizations to focus on the delivery of high-quality patient care,” explained — Bill Frist, M.D. — Partner at Frist Cressey Ventures. “The product suite offered by Stratasan is best in class; their data and analytics decisioning products are a must-have for any healthcare entity looking to grow intelligently.”
Stratasan is partnered with over 1,000 hospitals from the nation’s top healthcare systems across 40+ states.
“We invest in companies that have a truly differentiated offering in the market, and Stratasan provides that. We look forward to working closely with the team and are excited about what the future holds,” noted Blue Heron Capital Principal Gordon Crenshaw.
